Forte Biosciences, Inc. - Common Stock (FBRX)
CUSIP: 34962G208
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 12,506,886
- Total 13F shares
- 11,522,905
- Share change
- +1,950,222
- Total reported value
- $314,510,108
- Price per share
- $27.27
- Number of holders
- 59
- Value change
- +$55,513,195
- Number of buys
- 44
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 34962G208?
CUSIP 34962G208 identifies FBRX - Forte Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34962G208:
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
11%
|
1,425,785
|
$38,881,157 | +$20,950,887 | 31 Dec 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
13%
|
1,636,030
|
$24,540,450 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
13D/G
|
Company |
13%
from 13D/G
|
1,635,380
|
$24,530,700 | — | 30 Sep 2025 | |
| ALGER ASSOCIATES INC |
13D/G
|
— |
13%
|
1,634,267
|
$24,514,005 | +$234,270 | 30 Sep 2025 | |
| ORBIMED ADVISORS LLC |
13F
13D/G
|
Company |
8%
from 13D/G
|
1,196,955
|
$17,954,325 | — | 30 Sep 2025 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13D/G
13F
|
Company |
10%
|
1,268,086
|
$13,378,307 | +$6,618,184 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
566,741
|
$8,501,115 | — | 30 Sep 2025 | |
| Cable Car Capital, LP |
13F
|
Company |
4%
|
500,000
|
$7,500,000 | — | 30 Sep 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
3.8%
|
474,309
|
$7,114,635 | — | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13D/G
13F
|
Company |
5%
|
617,667
|
$6,516,387 | +$89,063 | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.7%
|
333,333
|
$4,999,995 | — | 30 Sep 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.7%
|
331,987
|
$4,979,805 | — | 30 Sep 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
2.1%
|
261,821
|
$3,927,315 | — | 30 Sep 2025 | |
| FMR LLC |
13F
|
Company |
2%
|
244,400
|
$3,666,000 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.96%
|
119,812
|
$1,797,180 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.87%
|
108,318
|
$1,625,099 | — | 30 Sep 2025 | |
| Mink Brook Asset Management LLC |
13F
|
Company |
0.65%
|
81,312
|
$1,219,680 | — | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
|
— |
2.5%
|
163,935
|
$1,209,840 | $0 | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.56%
|
69,892
|
$1,048,380 | — | 30 Sep 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
0.5%
|
65,350
|
$980,250 | -$8,674,080 | 30 Sep 2025 | |
| BVF INC/IL |
13F
|
Company |
0.52%
|
65,350
|
$980,250 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.41%
|
50,662
|
$759,930 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.3%
|
38,097
|
$571,455 | — | 30 Sep 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13D/G
|
— |
0.8%
|
53,791
|
$567,495 | -$369,187 | 30 Jun 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.19%
|
23,347
|
$350,205 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
23,285
|
$349,275 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.15%
|
19,165
|
$287,475 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
16,200
|
$243,000 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
15,633
|
$234,495 | — | 30 Sep 2025 | |
| AlphaQuest LLC |
13F
|
Company |
0.1%
|
12,291
|
$184,365 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.09%
|
11,253
|
$169,000 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.09%
|
10,765
|
$161,008 | — | 30 Sep 2025 | |
| Hubert C. Chen |
3/4/5
|
President and Chief Scientific Officer |
—
mixed-class rows
|
183,405
mixed-class rows
|
$150,704 | — | 01 Jan 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
3,158
|
$47,370 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,560
|
$23,400 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
820
|
$12,300 | — | 30 Sep 2025 | |
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
3.4%
|
221,027
|
$12,130 | $0 | 31 Dec 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
553
|
$8,295 | — | 30 Sep 2025 | |
| PRIVATE TRUST CO NA |
13F
|
Company |
0%
|
274
|
$4,110 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
162
|
$2,430 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
151
|
$2,265 | — | 30 Sep 2025 | |
| COMERICA BANK |
13F
|
Company |
0%
|
150
|
$2,250 | — | 30 Sep 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
104
|
$1,560 | — | 30 Sep 2025 | |
| ASSETMARK, INC |
13F
|
Company |
0%
|
81
|
$1,215 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
13
|
$195 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
8
|
$120 | — | 30 Sep 2025 | |
| REAP Financial Group, LLC |
13F
|
Company |
0%
|
3
|
$45 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2
|
$30 | — | 30 Sep 2025 | |
| Donald Allen Williams |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 20 Aug 2024 | |
| Lawrence Eichenfield |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 20 Aug 2024 |
Institutional Holders of Forte Biosciences, Inc. - Common Stock (FBRX) as of Q4 2025
As of 31 Dec 2025,
Forte Biosciences, Inc. - Common Stock (FBRX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,522,905 shares.
The largest 10 holders included
FEDERATED HERMES, INC., FRED ALGER MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, ORBIMED ADVISORS LLC, Affinity Asset Advisors, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., Cable Car Capital, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and Woodline Partners LP.
This page lists
59
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
42
Q4 2025 holders
59
Holder diff
17
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.